Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
Connective tissue diseases (CTDs) are a heterogenous group of systemic inflammatory disorders. The development of connective tissue disease-associated interstitial lung disease (CTD-ILD) is a key complication associated with significant morbidity and mortality. The aim of this review is to explore t...
Main Authors: | Antoniya Kamenova, Argyris Tzouvelekis, George A. Margaritopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1155771/full |
Similar Items
-
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
by: Gian Luca Erre, et al.
Published: (2020-08-01) -
Interstitial pneumonia with autoimmune features
by: Uma Karjigi, et al.
Published: (2021-01-01) -
Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01) -
Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
by: Wang Pengfei, et al.
Published: (2023-11-01) -
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)